BOMYNTRA
Denosumab
- Strength
- 70 mg/mL
- Form
- Injection
- Class
- RANK Ligand Inhibitor
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Denosumab-kyqq
Listed by Biocon Biologics Inc.
| Dosage form | Injection |
|---|---|
| Route | Subcutaneous |
| Drug class | RANK Ligand Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 83257-030 |
| FDA application | BLA761436 |
| RxNorm concept | 2725939 |
| Package sizes listed | 1 |
| Marketed since | January 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Denosumab
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Denosumab
Fresenius Kabi USA, LLC
Not stocked by us — reference only
denosumab-mobz
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
Denosumab-kyqq
Biocon Biologics Inc.
Not stocked by us — reference only
Denosumab
Fresenius Kabi USA, LLC
Not stocked by us — reference only
CELLTRION USA, Inc.
Not stocked by us — reference only
CELLTRION USA, Inc.
Not stocked by us — reference only
Denosumab-qbde
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.